Journal Watch · Neuron · 2026

Clinical connectomics: Mapping structural brain networks in disease.

Our aim is to establish best practices for connectome mapping and analysis in neurology, psychiatry, and neurosurgery.

Zalesky A, Di Biase MANeuron3 min readPharma relevance 30/100

DOI: 10.1016/j.neuron.2026.02.007PMID: 41887212Study type: clinical study

TL;DR

Our aim is to establish best practices for connectome mapping and analysis in neurology, psychiatry, and neurosurgery.

Key findings

  • We consider connectome-mapping pipelines and algorithmic choices to facilitate reliable and biologically meaningful clinical connectome mapping.
  • Our aim is to establish best practices for connectome mapping and analysis in neurology, psychiatry, and neurosurgery.

What they did

Here, we consider the challenges of structural connectome mapping in the presence of pathology. We first classify connectome abnormalities and relate them to underlying white-matter microstructure. We explain how measures of structural connectivity can quantify the impact of microstructural white-matter pathology on the macroscale connectome, including measures based on streamline counts, microstructure-informed tractography, tract-averaged metrics, and structural similarity.

Full abstract (original)

Background: The human connectome holds considerable promise for advancing an integrated, systems-level understanding of brain disorders. Critical to this ambition is accurate, reliable, and biologically informative connectome mapping and analysis in the presence of diverse brain pathologies. However, many connectome-mapping methodologies have been established and validated using healthy, non-clinical participants.

What they did: Here, we consider the challenges of structural connectome mapping in the presence of pathology. We first classify connectome abnormalities and relate them to underlying white-matter microstructure. We explain how measures of structural connectivity can quantify the impact of microstructural white-matter pathology on the macroscale connectome, including measures based on streamline counts, microstructure-informed tractography, tract-averaged metrics, and structural similarity.

Results & conclusions: We consider connectome-mapping pipelines and algorithmic choices to facilitate reliable and biologically meaningful clinical connectome mapping. Our aim is to establish best practices for connectome mapping and analysis in neurology, psychiatry, and neurosurgery.

Abstract © the authors / Neuron (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.neuron.2026.02.007 · PubMed 41887212.

Why it matters for pharma & biotech

  • Relevant to Biology & Life Sciences teams tracking Neuron for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Neuron study find?

Our aim is to establish best practices for connectome mapping and analysis in neurology, psychiatry, and neurosurgery.

What type of study is this?

It is a clinical study, published in Neuron in 2026. Here, we consider the challenges of structural connectome mapping in the presence of pathology.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.neuron.2026.02.007. PubMed ID: 41887212. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zalesky A, Di Biase MA. Clinical connectomics: Mapping structural brain networks in disease.. Neuron (2026). DOI: 10.1016/j.neuron.2026.02.007.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/clinical-connectomics-mapping-structural-brain-networks-in-disease-602007/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides